Skip to main content

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

Agency: Centers for Disease Control - NCHHSTP

Assistance Listings
  • 93.270 -- Viral Hepatitis Prevention and Control

Forecasted opportunityLast Updated: Sep 22, 2026

Important dates

  • Forecasted post date: December 1, 2026
  • Forecasted application due date: February 16, 2027
  • Forecasted award date: April 1, 2027
  • Forecasted project start date: May 1, 2027
  • Fiscal Year: 2027

Award details

  • Expected project funding: $450,000,000
  • Expected awards: 60

Award min.

$0

Award max.

$0

  • Funding opportunity number:CDC-RFA-PS-27-0009
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: June 9, 2026
  • Archive date: March 18, 2027
  • Version: 5

View version history on Grants.gov

Summary

This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings.

This multi-component NOFO includes two required components and two optional components:

  • Component 1: Outbreak Response and Surveillance (Required)
  • Component 2: Planning, Partnerships, and Promotion (Required)
  • Component 3: Testing, Treatment, and Prevention (Optional)
  • Component 4: Perinatal Hepatitis C Program (Optional)

This NOFO is alignment with CDC priorities. 

Eligibility

Government

  • State governments
  • City or township governments
  • Special district governments
  • County governments

Miscellaneous

  • Other

Additional information on eligibility

Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia. Local health agencies or their bona fide agents. If the city does not have a public health department, then the county covering the jurisdiction may apply (i.e., Los Angeles, CA covered by Los Angeles County and Phoenix, AZ covered by Maricopa County). All U.S. territories Bona fide agents must submit documentation that demonstrates their arrangement with the eligible applicant.

Documents

No documents are currently available.

Agency contact information

Email: mix4@cdc.gov

mix4@cdc.gov

Clarisse Tsang 404-718-5360

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov